AB
AVBP icon

Amalgamated Bank’s ArriVent BioPharma AVBP Stock Holding History

Amalgamated Bank’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-927
Closed -$19K – 2837
2025
Q4 		$19K Sell
927
-36
-4% -$749 ﹤0.01% 2139
2025
Q3 		$18K Hold
963
– – ﹤0.01% 2182
2025
Q2 		$21K Hold
963
– – ﹤0.01% 2104
2025
Q1 		$18K Hold
963
– – ﹤0.01% 2110
2024
Q4 		$26K Hold
963
– – ﹤0.01% 2025
2024
Q3 		$23K Buy
963
+423
+78% +$9.6K ﹤0.01% 2086
2024
Q2 		$10K Hold
540
– – ﹤0.01% 2480
2024
Q1 		$10K Buy
+540
New +$10.9K ﹤0.01% 2469

Other funds holding AVBP

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Amalgamated Bank's AVBP Position: Q1 2026 in Review

Amalgamated Bank sold out of ArriVent BioPharma (AVBP) in Q1 2026, closing a stake of 927 shares — an estimated $19K sold.

Amalgamated Bank first reported a position in AVBP in Q1 2024 and held it in 8 quarters. The position peaked at $26K in Q4 2024. 139 funds tracked by Wall St. Rank hold AVBP as of Q1 2026.

  • Amalgamated Bank reported no remaining ArriVent BioPharma position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 927 ArriVent BioPharma shares in Q1 2026, an estimated $19K.
  • Amalgamated Bank first reported a position in ArriVent BioPharma in Q1 2024 and held it in 8 quarters.
  • Amalgamated Bank's ArriVent BioPharma position peaked at $26K in Q4 2024.
  • 139 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.